Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $15.14 MXN
Change Today -0.07 / -0.46%
Volume 2.5M
LABB On Other Exchanges
Symbol
Exchange
Mexico
Berlin
OTC US
As of 4:09 PM 08/4/15 All times are local (Market data is delayed by at least 15 minutes).

genomma lab internacional-b (LABB) Snapshot

Open
$15.16
Previous Close
$15.21
Day High
$15.24
Day Low
$15.05
52 Week High
08/25/14 - $36.50
52 Week Low
03/4/15 - $8.75
Market Cap
15.9B
Average Volume 10 Days
4.3M
EPS TTM
$1.34
Shares Outstanding
1.0B
EX-Date
--
P/E TM
11.3x
Dividend
--
Dividend Yield
--
Current Stock Chart for GENOMMA LAB INTERNACIONAL-B (LABB)

Related News

No related news articles were found.

genomma lab internacional-b (LABB) Related Businessweek News

No Related Businessweek News Found

genomma lab internacional-b (LABB) Details

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, develops, markets, and sells over-the-counter pharmaceutical products, generic drugs, and personal care products in Mexico and internationally. The company offers approximately 112 own brands covering various product categories, including anti-acne products, generic drugs, sexual protection and enhancement products, hemorrhoid treatments, varicose vein treatments, hair loss treatments, topical analgesics, antacids, topical antifungals, colitis treatments, anti stress treatments, osteoarthritis treatments, soaps, multivitamins, shampoos, and flu treatments, as well as creams to enhance the appearance of scars. It also provides air transportation services. The company was founded in 1996 and is based in Mexico City, México.

Founded in 1996

genomma lab internacional-b (LABB) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

genomma lab internacional-b (LABB) Key Developments

Genomma Seeks Partner

Genomma Lab Internacional SAB de CV (BMV:LAB B) is seeking partner. Kimberly Clark is considering to license some of the non core brands of Genomma Lab that is seeking a partner for this OTC business. Genomma is to focus in core brands. On the other hand Kimberly has improved its performance in Mexico from April - June to 10.2% on net sales and 165% on EBIITDA.

Genomma Lab Internacional SAB de CV Announces Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015

Genomma Lab Internacional SAB de CV announced consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported net sales of MXN 2,974.7 million compared with MXN 2,900.0 million for the same period a year ago. EBITDA was MXN 602.2 million compared with MXN 613.5 million for the same period a year ago. Operating income was MXN 567.7 million compared with MXN 589.4 million for the same period a year ago. Net income of majority shareholders was MXN 358.8 million compared with MXN 308.0 million for the same period a year ago. Adjusted EBITDA decreased 1.8% to MXN 602.2 million in the second quarter of 2015, compared to MXN 613.5 million in the second quarter of 2014. Income before income taxes was MXN 519,300,000 compared with MXN 475,934,000 for the same period a year ago. Income from continuing operations was MXN 351,575,000 compared with MXN 326,589,000 for the same period a year ago. For the six months, the company reported net sales of MXN 5,743.2 million compared with MXN 5,338.1 million for the same period a year ago. EBITDA was MXN 1,051.6 million compared with MXN 989.8 million for the same period a year ago. Operating income was MXN 979.2 million compared with MXN 946.9 million for the same period a year ago. Net income of majority shareholders was MXN 496.8 million compared with MXN 461.4 million for the same period a year ago. Income before income taxes was MXN 759,976,000 compared with MXN 743,267,000 for the same period a year ago. Income from continuing operations was MXN 477,317,000 compared with MXN 505,713,000 for the same period a year ago. Net cash generated in operating activities was MXN 300,344,000 compared with MXN 789,781,000 for the same period a year ago. Acquisitions of plant, property and equipment were MXN 9,306,000 compared with MXN 16,620,000 for the same period a year ago.

Genomma Lab Internacional SAB de CV Announces Executive Changes

Genomma Lab Internacional SAB de CV announced that Rodrigo Herrera Aspra will continue to act as Chairman of the Board of Directors and President of the Operations Committee, leaving the position of Chief Executive Officer (CEO) to Maximo Juda, who has more than 12 years of experience at Genomma Lab. Mr. Juda occupied the position of Executive Vice-President and Chief Operating Officer since December, 2014. Previous to that, he was the International Operations Vice-president and he leaded the expansion to Argentina, Brazil and the USA. Mr. Juda holds a bachelor degree in Business Administration from the San Andres University in Argentina. This change will take effect immediately.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LABB:MM $15.14 MXN -0.07

LABB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for LABB.
View Industry Companies
 

Industry Analysis

LABB

Industry Average

Valuation LABB Industry Range
Price/Earnings 11.0x
Price/Sales 1.3x
Price/Book 1.4x
Price/Cash Flow 10.4x
TEV/Sales 0.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENOMMA LAB INTERNACIONAL-B, please visit www.genommalab.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.